Sector: Consumer Cyclicals | Industry: Miscellaneous Specialty Retailers |
Company Contact | |
Address: | 510 Seymour Street, Suite 1020 VANCOUVER BC V6B 3J5 |
Tel: | N/A |
Website: | https://www.kits.com |
IR: | See website |
Key People | ||
Roger V. Hardy Chairman of the Board, Chief Executive Officer | Sabrina Liak President, Chief Financial Officer, Company Secretary, Director | Joseph Thompson Chief Operating Officer |
Arshil Abdulla Chief Technology Officer | Rob Long Chief Information Officer | Stefan Harvalias Chief Marketing Officer |
Business Overview |
Kits Eyecare Ltd. is a Canada-based provider of vertically integrated and digitally native eyecare platforms. The Company operates through the sale of eyewear products to consumers. It offers customers access to a selection of contact lenses and eyeglasses, including its own KITS-designed products, as well as an advanced suite of online vision tools. Its collections include South Beach, Little Italy, Trail Blazer, KITS x Vasuma and Apres. The Company's designer glasses and sunglasses, including Alexander Mcqueen, Armourx, Betsey Johnson, Bottega Veneta, Calvin Klein Carrera, David Beckham, Diesel, Dior, Emilio Pucci, Emporio Armani, Gucci, Hugo Boss, Jimmy Choo, Judith Leiber, Kits, Persol, Prada, Ray-Ban, Superdry, Tom Ford, Under Armour, And Versace. |
Financial Overview |
For the three months ended 31 March 2024, Kits Eyecare Ltd revenues increased 26% to C$34.8M. Net income totaled C$64K vs. loss of C$1M. Revenues reflect United States of America segment increase of 20% to C$23.9M, Canada segment increase of 42% to C$10.9M. Net Income reflects Exchange (gain)/loss decrease from C$39K (expense) to C$821K (income), Depreciation and amortization decrease of 14% to C$516K (expense). |
Employees: | 143 as of Dec 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $202.01M as of Mar 31, 2024 |
Annual revenue (TTM): | $127.63M as of Mar 31, 2024 |
EBITDA (TTM): | $2.10M as of Mar 31, 2024 |
Net annual income (TTM): | -$1.13M as of Mar 31, 2024 |
Free cash flow (TTM): | $3.93M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 31,450,102 as of Mar 31, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |